Evaluation of endometrial biomarkers for semi-invasive diagnosis of endometriosis

Cleophas Kyama, Cleophas M Kyama, Attila Mihalyi, Mihalyi A, Olivier Gevaert, Etienne Waelkens, Waelkens E, Peter Simsa, Simsa P, Péter Simsa, Raf Van de Plas, Christel Meuleman, Meuleman C, De Moor B, Bart De Moor, D'Hooghe TM, Thomas D’Hooghe, Thomas M D'Hooghe
Fertility and sterility · 2010 · vol. 95(4) , pp. 1338–1343.e3 · doi:10.1016/j.fertnstert.2010.06.084 · PMID:20800833 · W2096980885
article OA: closed CC0 ⤵ 40 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This study evaluated endometrial biomarkers as a method for the semi-invasive diagnosis of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo test the hypothesis that specific proteins and peptides are expressed differentially in eutopic endometrium of women with and without endometriosis and at specific stages of the disease (minimal, mild, moderate, or severe) during the secretory phase.DesignPatients with endometriosis were compared with controls.SettingUniversity hospital.Patient(s)A total of 29 patients during the secretory phase were selected for this study on the basis of cycle phase and presence or absence of endometriosis.Intervention(s)Endometriosis was confirmed laparoscopically and histologically in 19 patients with endometriosis of revised American Society for Reproductive Medicine stages (9 minimal-mild and 10 moderate-severe), and the presence of a normal pelvis was documented by laparoscopy in 10 controls.Main outcome measure(s)Protein expression of endometrium was evaluated with use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. The differential expression of protein mass peaks was analyzed with use of support vector machine algorithms and logistic regression models.Result(s)Data preprocessing resulted in differential expression of 73, 30, and 131 mass peaks between controls and patients with endometriosis (all stages), with minimal-mild endometriosis, and with moderate-severe endometriosis, respectively. Endometriosis was diagnosed with high sensitivity (89.5%) and specificity (90%) with use of five down-regulated mass peaks (1.949 kDa, 5.183 kDa, 8.650 kDa, 8.659 kDa, and 13.910 kDa) obtained after support vector machine ranking and logistic regression classification. With use of a similar analysis, minimal-mild endometriosis was diagnosed with four mass peaks (two up-regulated: 35.956 kDa and 90.675 kDa and two down-regulated: 1.924 kDa and 2.504 kDa) with maximal sensitivity (100%) and specificity (100%). The 90.675-kDa and 35.956-kDa mass peaks were identified as T-plastin and annexin V, respectively.Conclusion(s)Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry analysis of secretory phase endometrium combined with bioinformatics puts forward a prospective panel of potential biomarkers with sensitivity of 100% and specificity of 100% for the diagnosis of minimal to mild endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometrium Adult Biomarkers Biomarkers Endometriosis Endometriosis Endometrium Endometrium Female Humans Prospective Studies Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Young Adult

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Cited by (40)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:00.782903+00:00
License: CC0 · commercial use OK